Literature DB >> 24101764

Central line maintenance bundles and CLABSIs in ambulatory oncology patients.

Michael L Rinke1, David G Bundy, Allen R Chen, Aaron M Milstone, Elizabeth Colantuoni, Miriana Pehar, Cynthia Herpst, Lisa Fratino, Marlene R Miller.   

Abstract

OBJECTIVE: Pediatric oncology patients are frequently managed with central lines as outpatients, and these lines confer significant morbidity in this immune-compromised population. We aimed to investigate whether a multidisciplinary, central line maintenance care bundle reduces central line-associated bloodstream infections (CLABSIs) and bacteremias in ambulatory pediatric oncology patients.
METHODS: We conducted an interrupted time-series study of a maintenance bundle concerning all areas of central line care. Each of 3 target groups (clinic staff, homecare agency nurses, and patient families) (1) received training on the bundle and its importance, (2) had their practice audited, and (3) were shown CLABSI rates through graphs, in-service training, and bulletin boards. CLABSI and bacteremia person-time incidence rates were collected for 23 months before and 24 months after beginning the intervention and were compared by using a Poisson regression model.
RESULTS: The mean CLABSI rate decreased by 48% from 0.63 CLABSIs per 1000 central line days at baseline to 0.32 CLABSIs per 1000 central line days during the intervention period (P = .005). The mean bacteremia rate decreased by 54% from 1.27 bacteremias per 1000 central line days at baseline to 0.59 bacteremias per 1000 central line days during the intervention period (P < .001).
CONCLUSIONS: Implementation of a multidisciplinary, central line maintenance care bundle significantly reduced CLABSI and bacteremia person-time incidence rates in ambulatory pediatric oncology patients with central lines. Further research is needed to determine if maintenance care bundles reduce ambulatory CLABSIs and bacteremia in other adult and pediatric populations.

Entities:  

Keywords:  central line–associated bloodstream infection; central venous catheter/access device; epidemiology; oncology; outpatient management; pediatric; quality improvement

Mesh:

Year:  2013        PMID: 24101764      PMCID: PMC3813391          DOI: 10.1542/peds.2013-0302

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  32 in total

1.  Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies.

Authors:  Craig R Ramsay; Lloyd Matowe; Roberto Grilli; Jeremy M Grimshaw; Ruth E Thomas
Journal:  Int J Technol Assess Health Care       Date:  2003       Impact factor: 2.188

2.  Catheter-associated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence.

Authors:  Amos Adler; Isaac Yaniv; Ester Solter; Enrique Freud; Zmira Samra; Jerry Stein; Salvador Fisher; Itzhak Levy
Journal:  J Pediatr Hematol Oncol       Date:  2006-01       Impact factor: 1.289

Review 3.  Patient involvement in patient safety: what factors influence patient participation and engagement?

Authors:  Rachel E Davis; Rosamond Jacklin; Nick Sevdalis; Charles A Vincent
Journal:  Health Expect       Date:  2007-09       Impact factor: 3.377

4.  Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.

Authors:  A Adler; I Yaniv; R Steinberg; E Solter; Z Samra; J Stein; I Levy
Journal:  J Hosp Infect       Date:  2006-01-10       Impact factor: 3.926

5.  All-or-none measurement raises the bar on performance.

Authors:  Thomas Nolan; Donald M Berwick
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

6.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

7.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.

Authors:  D Pittet; D Tarara; R P Wenzel
Journal:  JAMA       Date:  1994-05-25       Impact factor: 56.272

8.  Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.

Authors:  Dianne Pulte; Adam Gondos; Hermann Brenner
Journal:  J Natl Cancer Inst       Date:  2008-09-09       Impact factor: 13.506

9.  Polymicrobial bloodstream infections among children and adolescents with central venous catheters evaluated in ambulatory care.

Authors:  Kevin J Downes; Joshua P Metlay; Louis M Bell; Karin L McGowan; Michael R Elliott; Samir S Shah
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

10.  Risk determinants for catheter-associated blood stream infections in children and young adults with cancer.

Authors:  Rebekah C Allen; Mark T Holdsworth; Cynthia A Johnson; Cathy M Chavez; Richard L Heideman; Gary Overturf; David Lemon; W Curtis Hunt; Stuart S Winter
Journal:  Pediatr Blood Cancer       Date:  2008-07       Impact factor: 3.167

View more
  15 in total

1.  Bringing central line-associated bloodstream infection prevention home: catheter maintenance practices and beliefs of pediatric oncology patients and families.

Authors:  Michael L Rinke; Allen R Chen; Aaron M Milstone; Lindsay C Hebert; David G Bundy; Elizabeth Colantuoni; Lisa Fratino; Cynthia Herpst; Michelle Kokoszka; Marlene R Miller
Journal:  Jt Comm J Qual Patient Saf       Date:  2015-04

2.  Readmission Diagnoses After Pediatric Severe Sepsis Hospitalization.

Authors:  Erin F Carlton; Joseph G Kohne; Manu Shankar-Hari; Hallie C Prescott
Journal:  Crit Care Med       Date:  2019-04       Impact factor: 7.598

3.  Medically Attended Catheter Complications Are Common in Patients With Outpatient Central Venous Catheters.

Authors:  Steven S Spires; Peter F Rebeiro; Mickie Miller; Katie Koss; Patty W Wright; Thomas R Talbot
Journal:  Infect Control Hosp Epidemiol       Date:  2018-02-15       Impact factor: 3.254

4.  Do Clinicians Understand Quality Metric Data? An Evaluation in a Twitter-Derived Sample.

Authors:  Sushant Govindan; Vineet Chopra; Theodore J Iwashyna
Journal:  J Hosp Med       Date:  2017-01       Impact factor: 2.960

5.  Adverse Events in Hospitalized Pediatric Patients.

Authors:  David C Stockwell; Christopher P Landrigan; Sara L Toomey; Samuel S Loren; Jisun Jang; Jessica A Quinn; Sepideh Ashrafzadeh; Michelle J Wang; Melody Wu; Paul J Sharek; David C Classen; Rajendu Srivastava; Gareth Parry; Mark A Schuster
Journal:  Pediatrics       Date:  2018-07-13       Impact factor: 7.124

6.  Alcohol-impregnated caps and ambulatory central-line-associated bloodstream infections (CLABSIs): A randomized clinical trial.

Authors:  Aaron M Milstone; Carol Rosenberg; Gayane Yenokyan; Danielle W Koontz; Marlene R Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2020-10-12       Impact factor: 3.254

Review 7.  Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis.

Authors:  C E Dandoy; M I Ardura; G A Papanicolaou; J J Auletta
Journal:  Bone Marrow Transplant       Date:  2017-03-27       Impact factor: 5.174

8.  Development of a Clinical Prediction Model for Central Line-Associated Bloodstream Infection in Children Presenting to the Emergency Department.

Authors:  Laura M Figueroa-Phillips; Christopher P Bonafide; Susan E Coffin; Michelle E Ross; James P Guevara
Journal:  Pediatr Emerg Care       Date:  2020-11       Impact factor: 1.602

Review 9.  Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on?

Authors:  Arne Simon; Rhoikos Furtwängler; Norbert Graf; Hans Jürgen Laws; Sebastian Voigt; Brar Piening; Christine Geffers; Philipp Agyeman; Roland A Ammann
Journal:  GMS Hyg Infect Control       Date:  2016-05-12

10.  Impact of a modified Broviac maintenance care bundle on bloodstream infections in paediatric cancer patients.

Authors:  Rhoikos Furtwängler; Carolin Laux; Norbert Graf; Arne Simon
Journal:  GMS Hyg Infect Control       Date:  2015-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.